Replay available

CAMP4 Therapeutics Corporation (CAMP) Q3 2023 Earnings Call

CAMP4 Therapeutics Corporation (NASDAQ: CAMP) Q3 2023 earnings conference call, held 2022-12-20. Replay captured from the company's public earnings webcast.

Tue, December 20, 2022 at 5:00 PMendedReplay
CAMP4 Therapeutics Corporation (CAMP) Q3 2023 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Clay Williams

Goldman Sachs Representative (asking on behalf of Jerry Revich)

Cindy Zhang

Acting CFO, CalAMP

Joel Akramowitz

Managing Director, Shelton Group (Investor Relations)

Jeff Gardner

President & CEO, CalAMP

George Nodder

Analyst, Jefferies

Mike Latimore

Analyst, Northland Capital Market

Scott Searle

Analyst, Roth Capital

Replay transcript excerpt

Welcome to Cal Amps Third Quarter 2023 Financial Results Conference Call. My name is Hannah, and I will be your moderator for today's call. All lines will be muted during the presentation portion of the call with an opportunity for questions and answers at the end. If you would like to ask a question, please press star 1 on your telephone keypad. As a reminder, this call is being recorded. I would now like to introduce your host for today's conference call, Joel Akramowitz, Managing Director of Shelton Group, CalAMP's Investor Relations Firm. Joel, you may begin. Good afternoon and welcome to CalAMP's fiscal third quarter 2023 financial results conference call. I'm Joel Akramowitz, Managing Director of Shelton Group, CalAMP's Investor Relations Firm. With us today are CalAMP's President and Chief Executive Officer, Jeff Gardner, and Acting CFO, Cindy Zhang. Before we begin, I'd like to remind you that this call may contain forward-looking statements. While these forward-looking statements reflect CalM's best current judgment, they're subject to risks and uncertainties that could cause actual results to differ materially from those implied by these forward-looking projections. These risk factors are discussed in our regular SEC filings and in the earnings release issued today, which are available on our website. We undertake no obligation to revise or update any forward-looking statements to reflect future events or circumstances. Now, Jeff will begin today's call with a review of the company's recent operational highlights, and then Cindy will provide a more detailed review of the financial results, followed by a question and answer session. With that, it's my great pleasure to turn the call over to Calum's president and CEO, Jeff Gardner. Jeff, please go ahead. Than...

More from Camp4 Therapeutics Corporation